Related Experiment Videos
Type IV collagenases in invasive tumors
K Tryggvason1, M Höyhtyä, C Pyke
1Biocenter, University of Oulu, Finland.
Breast Cancer Research and Treatment
|January 1, 1993
Summary
Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) may play a role in cancer invasion. Elevated MMPs are observed in invasive tumors, but their exact roles and prognostic significance require further study.
Area of Science:
- Biochemistry
- Oncology
- Cell Biology
Background:
- Matrix metalloproteinases (MMPs) are implicated in tumor metastasis.
- An imbalance between MMPs and their inhibitors (TIMPs) may drive cancer invasion.
- Type IV collagenases, a subset of MMPs, are key enzymes in extracellular matrix degradation.
Purpose of the Study:
- To investigate the role of MMPs, specifically type IV collagenases, in tumors with metastatic potential.
- To explore the cellular origin and expression levels of MMPs at the invasive tumor front.
- To assess the potential prognostic significance of MMPs in cancer progression.
Main Methods:
- Analysis of MMP and TIMP levels in tumor tissues and cell cultures.
- Investigating the cellular sources of MMPs (tumor cells, stromal cells, macrophages).
- Comparing MMP expression in invasive versus in situ tumor components.
Main Results:
- MMPs, particularly type IV collagenases, are elevated in invasive tumors.
- Evidence suggests stromal cells and macrophages contribute to MMP production at the tumor front.
- Tumor cells with invasive potential secrete both 72 kDa and 92 kDa type IV collagenases.
Conclusions:
- MMPs and TIMPs imbalance is potentially linked to the invasive phenotype of tumors.
- The cellular origin of MMPs at the invasive front is complex and involves both tumor and stromal cells.
- Further research is needed to establish the precise roles and prognostic value of these collagenases in cancer.